German researchers are working on how to make battery production more adaptable. They say their scalable production system can be tailored to handle more flexible batteries made in different formats and from different materials. Read the full article in C&I Magazine.
Researchers have succeeded in modelling a complex molecule associated with a congenital muscle wasting disease, which could help to develop future treatments. Read the full article in C&I Magazine.
The great hope for an Alzheimer’s treatment for 2021 – aducanumab –is a monoclonal antibody from Biogen that removes amyloid beta peptide, a hallmark of disease. There’s been no new approved Alzheimer’s treatment for decades, and the US FDA is set to review aducanumab in June. Read the full article in C&I Magazine.